FDA Qualified Health Claims for Yogurt and Type 2 Diabetes

Trending News

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

Food and Drug Law at Keller and Heckman

Email

202-434-4100

Bio and Articles

Find Your Next Job !

Paralegal - Illinois

Social Services Attorney

Associate Litigation Attorney

Explore More Job Openings

FDA Announces Qualified Health Claim for Yogurt and Reduced Risk of Type 2 Diabetes

by: Food and Drug Law at Keller and Heckman of Keller and Heckman LLP - The Daily Intake

Friday, March 1, 2024

Print Mail Download info_icon_img

info_icon_img

On March 1, 2024, the U.S. Food and Drug Administration (FDA) announced in a letter of enforcement discretion that it does not object to the use of certain qualified health claims regarding the consumption of yogurt and reduced risk of type 2 diabetes, provided that the qualified health claims are worded so as not to mislead consumers, and that other factors for the use of the claim are met.
A health claim characterizes the relationship between a substance and a disease or health-related condition. A qualified health claim is supported by scientific evidence, but does not meet the more rigorous “significant scientific agreement” standard required for an authorized health claim.
The letter is in response to a petition submitted on behalf of Danone North America that requested the Agency to review this qualified health claim. The petition also noted that the evidence supports the health effects of yogurt as food rather than related to any single nutrient or compound and thus is independent of fat and sugar content. FDA determined that there is some credible evidence supporting a relationship between yogurt intake and reduced risk of type 2 diabetes, but this evidence is limited.
FDA considers 2 cups (3 servings) per week of yogurt to be the minimum amount for this qualified health claim. FDA intends to consider exercising its enforcement discretion for the following qualified health claims regarding the relationship between yogurt and reduced risk of type 2 diabetes:
- “Eating yogurt regularly, at least 2 cups (3 servings) per week, may reduce the risk of type 2 diabetes. FDA has concluded that there is limited information supporting this claim.”
- “Eating yogurt regularly, at least 2 cups (3 servings) per week, may reduce the risk of type 2 diabetes according to limited scientific evidence.”

Current Public Notices

Post Your Public Notice Today!

PUBLIC NOTICE OF UCC SALE: Broad St Ventures Urban Renewal, LLC

Published: 10 July, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: CCP Mezzanine Nashville I, LLC

Published: 7 July, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: Chenango Flats LLC

Published: 7 July, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: Integrated Endoscopy, Inc.

Published: 1 July, 2025

PUBLIC NOTICE OF ASSIGNMENT: Common Cents Distributors, LLC

Published: 26 June, 2025

PUBLIC NOTICE OF UCC SALE: Hudson 1702, LLC

Published: 24 June, 2025

PUBLIC NOTICE OF INTELLECTUAL PROPERTY SALE: American Energy Storage Innovations Inc.

Published: 24 June, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: Chesterfield Faring, LTD

Published: 24 June, 2025

PUBLIC NOTICE OF ASSIGNEE SALE: Quadrata, Inc.

Published: 23 June, 2025

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: HM LAND ACQUISITION, LLC AND M&H INVESTMENT GROUP, LLC

Published: 16 June, 2025

Discover more public notices

Current Legal Analysis

Ninth Circuit Rejects Certification of FLSA Collective Action on Personal Jurisdiction Grounds

by: Ryan H. Crosner , Harry M. Rowland, III

Beltway Buzz, July 11, 2025

by: James J. Plunkett

President Trump Signs Law with Over $1 Billion of AI Funding, and US Rescinds Chip Export Restrictions to China — AI: The Washington Report

by: Bruce D. Sokler , Alexander Hecht

UK Regulator Publishes Update on Dynamic Pricing Project and “Top Tips” for Businesses Using Dynamic Pricing

by: Carlton Daniel , Paul Jinks

(In)Authentic: The Importance of Due Diligence in the Art Market

by: Sheppard, Mullin, Richter, & Hampton LLP

More from Keller and Heckman LLP

FDA Official Says FDA Plans to Issue Guidance as Normal Despite “10-1 Executive Order”

by: Food and Drug Law at Keller and Heckman

Publication of an EU Action Plan for Chemicals and a Simplification Package

by: Ales Bartl , Alejandra Martínez Perea

New Louisiana Law Mandates Ingredient Disclosures & Bans Ingredients in Schools

by: Food and Drug Law at Keller and Heckman

European Union Releases Plans to Help Boost Novel Food Applications

by: Food and Drug Law at Keller and Heckman

FDA Publishes Proposed 2025 Human Foods Program Guidance Agenda

by: Food and Drug Law at Keller and Heckman

Texas Becomes Seventh State to Ban Lab-Grown Meat

by: Food and Drug Law at Keller and Heckman

CODEX ALIMENTARIUS: Main Outcome of the 34th Committee on General Principles (CCGP34)

by: Christophe Leprêtre

Update: Trump Asks Supreme Court to Rule on Authority to Remove CPSC Commissioners

by: Sheila A. Millar , Antonia Stamenova-Dancheva

FDA Updates Food Labeling Requirements Compliance Program

by: Food and Drug Law at Keller and Heckman

General Mills and Kraft Heinz Announce Voluntary Phase Outs of Synthetic Color Additives

by: Food and Drug Law at Keller and Heckman

Alcohol Consumption Limit Expected to be Removed from Dietary Guidelines

by: Food and Drug Law at Keller and Heckman

FDA Opens Public Comment Period for Chemical Post-Market Assessment Regulation

by: Food and Drug Law at Keller and Heckman

Texas Governor Signs ‘Make Texas Healthy Again’ Bill Mandating Food Warning Labels

by: Food and Drug Law at Keller and Heckman

California Delays NOP Requirements for Compostable Products

by: Sheila A. Millar , Anushka R. Stein

Democratic Commissioners Reinstated at CPSC – for Now

by: Sheila A. Millar , Antonia Stamenova-Dancheva

Upcoming Events

Jul

15

2025

Loper Bright: Has the Demise of Chevron Deference Mattered?

Jul

15

2025

Loper Bright: Has the Demise of Chevron Deference Mattered?

Jul

17

2025

180 Days of the Trump Administration—Quick Hits on Executive Orders, Actions, and Policies

Jul

17

2025

EPR for Packaging is Here and Expanding: What Cosmetic and Personal Care Products Companies Need to Know

Print